 | • レポートコード：GIR-107A14898 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ウィルムス腫瘍タンパク質のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ウィルムス腫瘍タンパク質の種類別市場規模（Elatipepimut-S、Galinpepimut-S、GSK-2130579A、INO-5401、OCV-501、その他）、用途別市場規模（副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ウィルムス腫瘍タンパク質の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline Plc、Inovio Pharmaceuticals Inc、Otsuka Holdings Co Ltd、Sellas Life Sciences Group Ltd、Sumitomo Dainippon Pharma Co Ltd、Vaximm AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Elatipepimut-S、Galinpepimut-S、GSK-2130579A、INO-5401、OCV-501、その他 ・用途別分析2016年-2026年：副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他 ・ウィルムス腫瘍タンパク質の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ウィルムス腫瘍タンパク質のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ウィルムス腫瘍タンパク質のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ウィルムス腫瘍タンパク質の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ウィルムス腫瘍タンパク質の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Wilms Tumor Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Wilms Tumor Protein size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Wilms Tumor Protein market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Wilms Tumor Protein market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Elatipepimut-S
Galinpepimut-S
GSK-2130579A
INO-5401
OCV-501
Others
Market segment by Application can be divided into
Adrenal Gland Cancer
High-Grade Glioma
Lung Cancer
Peritoneal Cancer
Others
The key market players for global Wilms Tumor Protein market are listed below:
GlaxoSmithKline Plc
Inovio Pharmaceuticals Inc
Otsuka Holdings Co Ltd
Sellas Life Sciences Group Ltd
Sumitomo Dainippon Pharma Co Ltd
Vaximm AG
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Wilms Tumor Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Wilms Tumor Protein, with price, sales, revenue and global market share of Wilms Tumor Protein from 2019 to 2021.
Chapter 3, the Wilms Tumor Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Wilms Tumor Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Wilms Tumor Protein market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Wilms Tumor Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Wilms Tumor Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Wilms Tumor Protein Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Elatipepimut-S
1.2.3 Galinpepimut-S
1.2.4 GSK-2130579A
1.2.5 INO-5401
1.2.6 OCV-501
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Wilms Tumor Protein Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adrenal Gland Cancer
1.3.3 High-Grade Glioma
1.3.4 Lung Cancer
1.3.5 Peritoneal Cancer
1.3.6 Others
1.4 Global Wilms Tumor Protein Market Size & Forecast
1.4.1 Global Wilms Tumor Protein Sales in Value (2016-2026))
1.4.2 Global Wilms Tumor Protein Sales in Volume (2016-2026)
1.4.3 Global Wilms Tumor Protein Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Wilms Tumor Protein Production Capacity Analysis
1.5.1 Global Wilms Tumor Protein Total Production Capacity (2016-2026)
1.5.2 Global Wilms Tumor Protein Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Wilms Tumor Protein Market Drivers
1.6.2 Wilms Tumor Protein Market Restraints
1.6.3 Wilms Tumor Protein Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline Plc
2.1.1 GlaxoSmithKline Plc Details
2.1.2 GlaxoSmithKline Plc Major Business
2.1.3 GlaxoSmithKline Plc Wilms Tumor Protein Product and Services
2.1.4 GlaxoSmithKline Plc Wilms Tumor Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Inovio Pharmaceuticals Inc
2.2.1 Inovio Pharmaceuticals Inc Details
2.2.2 Inovio Pharmaceuticals Inc Major Business
2.2.3 Inovio Pharmaceuticals Inc Wilms Tumor Protein Product and Services
2.2.4 Inovio Pharmaceuticals Inc Wilms Tumor Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Otsuka Holdings Co Ltd
2.3.1 Otsuka Holdings Co Ltd Details
2.3.2 Otsuka Holdings Co Ltd Major Business
2.3.3 Otsuka Holdings Co Ltd Wilms Tumor Protein Product and Services
2.3.4 Otsuka Holdings Co Ltd Wilms Tumor Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sellas Life Sciences Group Ltd
2.4.1 Sellas Life Sciences Group Ltd Details
2.4.2 Sellas Life Sciences Group Ltd Major Business
2.4.3 Sellas Life Sciences Group Ltd Wilms Tumor Protein Product and Services
2.4.4 Sellas Life Sciences Group Ltd Wilms Tumor Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sumitomo Dainippon Pharma Co Ltd
2.5.1 Sumitomo Dainippon Pharma Co Ltd Details
2.5.2 Sumitomo Dainippon Pharma Co Ltd Major Business
2.5.3 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Product and Services
2.5.4 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Vaximm AG
2.6.1 Vaximm AG Details
2.6.2 Vaximm AG Major Business
2.6.3 Vaximm AG Wilms Tumor Protein Product and Services
2.6.4 Vaximm AG Wilms Tumor Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Wilms Tumor Protein Sales by Manufacturer
3.1 Global Wilms Tumor Protein Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Wilms Tumor Protein Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Wilms Tumor Protein
3.4 Market Concentration Rate
3.4.1 Top 3 Wilms Tumor Protein Manufacturer Market Share
3.4.2 Top 6 Wilms Tumor Protein Manufacturer Market Share
3.5 Global Wilms Tumor Protein Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Wilms Tumor Protein Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Wilms Tumor Protein Market Size by Region
4.1.1 Global Wilms Tumor Protein Sales in Volume by Region (2016-2026)
4.1.2 Global Wilms Tumor Protein Revenue by Region (2016-2026)
4.2 North America Wilms Tumor Protein Revenue (2016-2026)
4.3 Europe Wilms Tumor Protein Revenue (2016-2026)
4.4 Asia-Pacific Wilms Tumor Protein Revenue (2016-2026)
4.5 South America Wilms Tumor Protein Revenue (2016-2026)
4.6 Middle East and Africa Wilms Tumor Protein Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Wilms Tumor Protein Sales in Volume by Type (2016-2026)
5.2 Global Wilms Tumor Protein Revenue by Type (2016-2026)
5.3 Global Wilms Tumor Protein Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Wilms Tumor Protein Sales in Volume by Application (2016-2026)
6.2 Global Wilms Tumor Protein Revenue by Application (2016-2026)
6.3 Global Wilms Tumor Protein Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Wilms Tumor Protein Sales by Type (2016-2026)
7.2 North America Wilms Tumor Protein Sales by Application (2016-2026)
7.3 North America Wilms Tumor Protein Market Size by Country
7.3.1 North America Wilms Tumor Protein Sales in Volume by Country (2016-2026)
7.3.2 North America Wilms Tumor Protein Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Wilms Tumor Protein Sales by Type (2016-2026)
8.2 Europe Wilms Tumor Protein Sales by Application (2016-2026)
8.3 Europe Wilms Tumor Protein Market Size by Country
8.3.1 Europe Wilms Tumor Protein Sales in Volume by Country (2016-2026)
8.3.2 Europe Wilms Tumor Protein Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Wilms Tumor Protein Sales by Type (2016-2026)
9.2 Asia-Pacific Wilms Tumor Protein Sales by Application (2016-2026)
9.3 Asia-Pacific Wilms Tumor Protein Market Size by Region
9.3.1 Asia-Pacific Wilms Tumor Protein Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Wilms Tumor Protein Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Wilms Tumor Protein Sales by Type (2016-2026)
10.2 South America Wilms Tumor Protein Sales by Application (2016-2026)
10.3 South America Wilms Tumor Protein Market Size by Country
10.3.1 South America Wilms Tumor Protein Sales in Volume by Country (2016-2026)
10.3.2 South America Wilms Tumor Protein Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Wilms Tumor Protein Sales by Type (2016-2026)
11.2 Middle East & Africa Wilms Tumor Protein Sales by Application (2016-2026)
11.3 Middle East & Africa Wilms Tumor Protein Market Size by Country
11.3.1 Middle East & Africa Wilms Tumor Protein Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Wilms Tumor Protein Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Wilms Tumor Protein Typical Distributors
12.3 Wilms Tumor Protein Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Wilms Tumor Protein Revenue by Type, (USD Million), 2021-2026
Table 2. Global Wilms Tumor Protein Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Plc Major Business
Table 5. GlaxoSmithKline Plc Wilms Tumor Protein Product and Services
Table 6. GlaxoSmithKline Plc Wilms Tumor Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Inovio Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Inovio Pharmaceuticals Inc Major Business
Table 9. Inovio Pharmaceuticals Inc Wilms Tumor Protein Product and Services
Table 10. Inovio Pharmaceuticals Inc Wilms Tumor Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Otsuka Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Otsuka Holdings Co Ltd Major Business
Table 13. Otsuka Holdings Co Ltd Wilms Tumor Protein Product and Services
Table 14. Otsuka Holdings Co Ltd Wilms Tumor Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sellas Life Sciences Group Ltd Basic Information, Manufacturing Base and Competitors
Table 16. Sellas Life Sciences Group Ltd Major Business
Table 17. Sellas Life Sciences Group Ltd Wilms Tumor Protein Product and Services
Table 18. Sellas Life Sciences Group Ltd Wilms Tumor Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sumitomo Dainippon Pharma Co Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Sumitomo Dainippon Pharma Co Ltd Major Business
Table 21. Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Product and Services
Table 22. Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Vaximm AG Basic Information, Manufacturing Base and Competitors
Table 24. Vaximm AG Major Business
Table 25. Vaximm AG Wilms Tumor Protein Product and Services
Table 26. Vaximm AG Wilms Tumor Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Wilms Tumor Protein Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 28. Global Wilms Tumor Protein Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Wilms Tumor Protein, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Wilms Tumor Protein Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 31. Head Office and Wilms Tumor Protein Production Site of Key Manufacturer
Table 32. Wilms Tumor Protein New Entrant and Capacity Expansion Plans
Table 33. Wilms Tumor Protein Mergers & Acquisitions in the Past Five Years
Table 34. Global Wilms Tumor Protein Sales by Region (2016-2021e) & (K Pcs)
Table 35. Global Wilms Tumor Protein Sales by Region (2021-2026) & (K Pcs)
Table 36. Global Wilms Tumor Protein Revenue by Region (2016-2021e) & (USD Million)
Table 37. Global Wilms Tumor Protein Revenue by Region (2021-2026) & (USD Million)
Table 38. Global Wilms Tumor Protein Sales by Type (2016-2021e) & (K Pcs)
Table 39. Global Wilms Tumor Protein Sales by Type (2021-2026) & (K Pcs)
Table 40. Global Wilms Tumor Protein Revenue by Type (2016-2021e) & (USD Million)
Table 41. Global Wilms Tumor Protein Revenue by Type (2021-2026) & (USD Million)
Table 42. Global Wilms Tumor Protein Price by Type (2016-2021e) & (USD/Pcs)
Table 43. Global Wilms Tumor Protein Price by Type (2021-2026) & (USD/Pcs)
Table 44. Global Wilms Tumor Protein Sales by Application (2016-2021e) & (K Pcs)
Table 45. Global Wilms Tumor Protein Sales by Application (2021-2026) & (K Pcs)
Table 46. Global Wilms Tumor Protein Revenue by Application (2016-2021e) & (USD Million)
Table 47. Global Wilms Tumor Protein Revenue by Application (2021-2026) & (USD Million)
Table 48. Global Wilms Tumor Protein Price by Application (2016-2021e) & (USD/Pcs)
Table 49. Global Wilms Tumor Protein Price by Application (2021-2026) & (USD/Pcs)
Table 50. North America Wilms Tumor Protein Sales by Country (2016-2021e) & (K Pcs)
Table 51. North America Wilms Tumor Protein Sales by Country (2021-2026) & (K Pcs)
Table 52. North America Wilms Tumor Protein Revenue by Country (2016-2021e) & (USD Million)
Table 53. North America Wilms Tumor Protein Revenue by Country (2021-2026) & (USD Million)
Table 54. North America Wilms Tumor Protein Sales by Type (2016-2021e) & (K Pcs)
Table 55. North America Wilms Tumor Protein Sales by Type (2021-2026) & (K Pcs)
Table 56. North America Wilms Tumor Protein Sales by Application (2016-2021e) & (K Pcs)
Table 57. North America Wilms Tumor Protein Sales by Application (2021-2026) & (K Pcs)
Table 58. Europe Wilms Tumor Protein Sales by Country (2016-2021e) & (K Pcs)
Table 59. Europe Wilms Tumor Protein Sales by Country (2021-2026) & (K Pcs)
Table 60. Europe Wilms Tumor Protein Revenue by Country (2016-2021e) & (USD Million)
Table 61. Europe Wilms Tumor Protein Revenue by Country (2021-2026) & (USD Million)
Table 62. Europe Wilms Tumor Protein Sales by Type (2016-2021e) & (K Pcs)
Table 63. Europe Wilms Tumor Protein Sales by Type (2021-2026) & (K Pcs)
Table 64. Europe Wilms Tumor Protein Sales by Application (2016-2021e) & (K Pcs)
Table 65. Europe Wilms Tumor Protein Sales by Application (2021-2026) & (K Pcs)
Table 66. Asia-Pacific Wilms Tumor Protein Sales by Region (2016-2021e) & (K Pcs)
Table 67. Asia-Pacific Wilms Tumor Protein Sales by Region (2021-2026) & (K Pcs)
Table 68. Asia-Pacific Wilms Tumor Protein Revenue by Region (2016-2021e) & (USD Million)
Table 69. Asia-Pacific Wilms Tumor Protein Revenue by Region (2021-2026) & (USD Million)
Table 70. Asia-Pacific Wilms Tumor Protein Sales by Type (2016-2021e) & (K Pcs)
Table 71. Asia-Pacific Wilms Tumor Protein Sales by Type (2021-2026) & (K Pcs)
Table 72. Asia-Pacific Wilms Tumor Protein Sales by Application (2016-2021e) & (K Pcs)
Table 73. Asia-Pacific Wilms Tumor Protein Sales by Application (2021-2026) & (K Pcs)
Table 74. South America Wilms Tumor Protein Sales by Country (2016-2021e) & (K Pcs)
Table 75. South America Wilms Tumor Protein Sales by Country (2021-2026) & (K Pcs)
Table 76. South America Wilms Tumor Protein Revenue by Country (2016-2021e) & (USD Million)
Table 77. South America Wilms Tumor Protein Revenue by Country (2021-2026) & (USD Million)
Table 78. South America Wilms Tumor Protein Sales by Type (2016-2021e) & (K Pcs)
Table 79. South America Wilms Tumor Protein Sales by Type (2021-2026) & (K Pcs)
Table 80. South America Wilms Tumor Protein Sales by Application (2016-2021e) & (K Pcs)
Table 81. South America Wilms Tumor Protein Sales by Application (2021-2026) & (K Pcs)
Table 82. Middle East & Africa Wilms Tumor Protein Sales by Country (2016-2021e) & (K Pcs)
Table 83. Middle East & Africa Wilms Tumor Protein Sales by Country (2021-2026) & (K Pcs)
Table 84. Middle East & Africa Wilms Tumor Protein Revenue by Country (2016-2021e) & (USD Million)
Table 85. Middle East & Africa Wilms Tumor Protein Revenue by Country (2021-2026) & (USD Million)
Table 86. Middle East & Africa Wilms Tumor Protein Sales by Type (2016-2021e) & (K Pcs)
Table 87. Middle East & Africa Wilms Tumor Protein Sales by Type (2021-2026) & (K Pcs)
Table 88. Middle East & Africa Wilms Tumor Protein Sales by Application (2016-2021e) & (K Pcs)
Table 89. Middle East & Africa Wilms Tumor Protein Sales by Application (2021-2026) & (K Pcs)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Wilms Tumor Protein Typical Distributors
Table 93. Wilms Tumor Protein Typical Customers
List of Figures
Figure 1. Wilms Tumor Protein Picture
Figure 2. Global Wilms Tumor Protein Sales Market Share by Type in 2020
Figure 3. Elatipepimut-S
Figure 4. Galinpepimut-S
Figure 5. GSK-2130579A
Figure 6. INO-5401
Figure 7. OCV-501
Figure 8. Others
Figure 9. Global Wilms Tumor Protein Sales Market Share by Application in 2020
Figure 10. Adrenal Gland Cancer
Figure 11. High-Grade Glioma
Figure 12. Lung Cancer
Figure 13. Peritoneal Cancer
Figure 14. Others
Figure 15. Global Wilms Tumor Protein Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Wilms Tumor Protein Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Wilms Tumor Protein Sales (2016-2026) & (K Pcs)
Figure 18. Global Wilms Tumor Protein Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Wilms Tumor Protein Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Wilms Tumor Protein Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Wilms Tumor Protein Market Drivers
Figure 22. Wilms Tumor Protein Market Restraints
Figure 23. Wilms Tumor Protein Market Trends
Figure 24. Global Wilms Tumor Protein Sales Market Share by Manufacturer in 2020
Figure 25. Global Wilms Tumor Protein Revenue Market Share by Manufacturer in 2020
Figure 26. Wilms Tumor Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Wilms Tumor Protein Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Wilms Tumor Protein Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Wilms Tumor Protein Sales Market Share by Region (2016-2026)
Figure 30. Global Wilms Tumor Protein Revenue Market Share by Region (2016-2026)
Figure 31. North America Wilms Tumor Protein Revenue (2016-2026) & (USD Million)
Figure 32. Europe Wilms Tumor Protein Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Wilms Tumor Protein Revenue (2016-2026) & (USD Million)
Figure 34. South America Wilms Tumor Protein Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Wilms Tumor Protein Revenue (2016-2026) & (USD Million)
Figure 36. Global Wilms Tumor Protein Sales Market Share by Type (2016-2026)
Figure 37. Global Wilms Tumor Protein Revenue Market Share by Type (2016-2026)
Figure 38. Global Wilms Tumor Protein Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Wilms Tumor Protein Sales Market Share by Application (2016-2026)
Figure 40. Global Wilms Tumor Protein Revenue Market Share by Application (2016-2026)
Figure 41. Global Wilms Tumor Protein Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Wilms Tumor Protein Sales Market Share by Type (2016-2026)
Figure 43. North America Wilms Tumor Protein Sales Market Share by Application (2016-2026)
Figure 44. North America Wilms Tumor Protein Sales Market Share by Country (2016-2026)
Figure 45. North America Wilms Tumor Protein Revenue Market Share by Country (2016-2026)
Figure 46. United States Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Wilms Tumor Protein Sales Market Share by Type (2016-2026)
Figure 50. Europe Wilms Tumor Protein Sales Market Share by Application (2016-2026)
Figure 51. Europe Wilms Tumor Protein Sales Market Share by Country (2016-2026)
Figure 52. Europe Wilms Tumor Protein Revenue Market Share by Country (2016-2026)
Figure 53. Germany Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Wilms Tumor Protein Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Wilms Tumor Protein Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Wilms Tumor Protein Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Wilms Tumor Protein Revenue Market Share by Region (2016-2026)
Figure 62. China Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Wilms Tumor Protein Sales Market Share by Type (2016-2026)
Figure 69. South America Wilms Tumor Protein Sales Market Share by Application (2016-2026)
Figure 70. South America Wilms Tumor Protein Sales Market Share by Country (2016-2026)
Figure 71. South America Wilms Tumor Protein Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Wilms Tumor Protein Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Wilms Tumor Protein Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Wilms Tumor Protein Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Wilms Tumor Protein Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Wilms Tumor Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界のセリンプロテインキナーゼ市場 2021：企業別、地域別、種類・用途別 The Serine Protein Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のプロテインホスファターゼ2A市場 2021：企業別、地域別、種類・用途別 The Protein Phosphatase 2A market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のマイトジェン活性化プロテインキナーゼ1市場 2021：企業別、地域別、種類・用途別 The Mitogen Activated Protein Kinase 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の転移性骨腫瘍治療市場 2021：企業別、地域別、種類・用途別 The Metastatic Bone Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…